Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Evolent Health, a prominent player in the healthcare industry, has recently garnered significant acquisition interest, making it the focus of sale talks.</li><li>As a company with both strengths and challenges, Evolent Health presents a complex investment thesis.</li><li>On the positive side, Evolent has demonstrated consistent revenue growth, a strong pipeline, and a strategic focus on delivering clinical value through its Performance Suite and Specialty Technology and Services.</li></ul>

Evolent Health, a prominent player in the healthcare industry, has recently garnered significant acquisition interest, making it the focus of sale talks.As a company with both strengths and challenges, Evolent Health presents a complex investment thesis.On the positive side, Evolent has demonstrated consistent revenue growth, a strong pipeline, and a strategic focus on delivering clinical value through its Performance Suite and Specialty Technology and Services.

Evolent Health: Why This Healthcare Player Is Now a Hot Acquisition Target? - Major Drivers

High Quality Stock Setups, Weekly Stock Bull Finder

Weekly Stock Bull Finder

High Quality Stock Setups

Finding high potential stock setups on quality companies

Thematic (Sector/Industry)

<ul><li>The war in Ukraine has thrown Europe into a full blown energy crisis that has resulted in a cost of living crisis for many EU countries as food and heating costs soar, manufacturing is hurt, and now new rationing measures are introduced ahead of the fall and winter. </li><li>Looking ahead this month, the Nord Stream 1 gas pipeline, will undergo its planned annual maintenance from July 11-21, when gas flows will drop to zero, but there are growing concerns that it will not resume operations on time or even worse, that Putin will refuse to turn the gas pipeline back on at all while Europe desperately attempts to fill storage before winter. </li><li>Just this past week, Russia cut gas flows to Europe to 40% of the pipeline's capacity, blaming delayed equipment repairs and leaving Germany and other European states racing to find alternative energy supplies.</li></ul>

The war in Ukraine has thrown Europe into a full blown energy crisis that has resulted in a cost of living crisis for many EU countries as food and heating costs soar, manufacturing is hurt, and now new rationing measures are introduced ahead of the fall and winter. Looking ahead this month, the Nord Stream 1 gas pipeline, will undergo its planned annual maintenance from July 11-21, when gas flows will drop to zero, but there are growing concerns that it will not resume operations on time or even worse, that Putin will refuse to turn the gas pipeline back on at all while Europe desperately attempts to fill storage before winter. Just this past week, Russia cut gas flows to Europe to 40% of the pipeline's capacity, blaming delayed equipment repairs and leaving Germany and other European states racing to find alternative energy supplies.

United States

Evolent Health, Inc. provides a purpose-built platform, powered by our technology, proprietary processes and integrated services, enables providers to migrate their economic orientation from fee-for-service, or FFS, reimbursement to payment models that reward high-quality and cost-effective care, or value-based payment models.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Evolent Health Inc A (EVH US)

Evolent Health: Why This Healthcare Player Is Now a Hot Acquisition Target? - Major Drivers

Evolent Health, a prominent player in the healthcare industry, has recently garnered significant acquisition interest, making it the focus of sale...

Baptista Research

Weekly Stock Bullfinder - Week of 7/11

The war in Ukraine has thrown Europe into a full blown energy crisis that has resulted in a cost of living crisis for many EU countries as food and...

Weekly Stock Bull Finder

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)